Skip to main content
PMC home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;26(6):415–418. [Article in Spanish] doi: 10.1016/S0212-6567(00)78692-6

Fibromialgia: un diagnóstico cenicienta

E Soriano Suárez a, MJ Gelado Ferrero b, MR Girona Bastus b
PMCID: PMC7681381  PMID: 11111315

The content is available as a PDF (90.8 KB).

Bibliografía

  • 1.Wolfe F., Ross K., Anderson J., Russell I.L., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19–28. doi: 10.1002/art.1780380104. [DOI] [PubMed] [Google Scholar]
  • 2.Robles Gómez E. Fibromialgia. Intoducción, conceptos y fisiopatología. Encuentros médicos. 1995:4–10. Mayo. [Google Scholar]
  • 3.Wolfe F. Fibromyalgia: the clinical syndrom. Rheum Dis Clin NA. 1989;15:1–12. [PubMed] [Google Scholar]
  • 4.Shafran S.D. The chronic fatigue syndrom. Am J Med. 1991;90:730–739. [PubMed] [Google Scholar]
  • 5.Bradley L.A., Young L.D., Anderson K.O., Turner R.A., Agudelo C.A., McDaniel L.K. Effects of psychological therapy on pain behavior of rheumatoid arthritis patients. Treatment outcome and sixmonth followup. Arthritis Rheum. 1987;30:1105–1114. doi: 10.1002/art.1780301004. [DOI] [PubMed] [Google Scholar]
  • 6.Vlaeyen J.W.S., Teeken-Gruben N.J.G., Goossens M.E.J.B., Rutten-van Mölken M.P.M.H., Pelt R.A.G.B., Van Eek H. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial: I. Clinical effects. J. Rheumatol. 1996;23:1237–1245. [PubMed] [Google Scholar]
  • 7.Buckelew S.P., Conway R., Parker J., Deuser W.E., Jennings J., Witty T.E. Biofeedback/ relaxation training and exercise interventions for fibromyalgia: a prospective trial. Arthritis Care Res. 1998;11:196–209. doi: 10.1002/art.1790110307. [DOI] [PubMed] [Google Scholar]
  • 8.McCain G.A., Bell D.A., Mai F.M., Halliday P.D. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988;31:1135–1141. doi: 10.1002/art.1780310908. [DOI] [PubMed] [Google Scholar]
  • 9.Martin L., Edwothy S.M., Macintosh B. Is exercise hepful in treatment of fibromyalgia? Arthritis Rheum. 1993;36(Supl):292. [Google Scholar]
  • 10.Jaeger B., Skootsky S.A. Double-blind controlled study of differente myofascial trigger point injection techniques. Pain. 1987;31(Supl):292. [Google Scholar]
  • 11.Wike W.S. Treatment o f reisitant fibromyalgia. Rheum Clin Dis North Am. 1995;21:247–260. [PubMed] [Google Scholar]
  • 12.Rothenberg M.D. New pain killwer may have special benefits for the treatment of fibromyalgia. Fibromyalgia Frontiers. 1995;3:5–6. [Google Scholar]
  • 13.Rusell I.J., Fltcher E.M., Michalek J.E., Mc Broom P.C., Hester G.G. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: doubleblind, pacebo-controlled study. Arthritis Rheum. 1991;34:552–560. doi: 10.1002/art.1780340507. [DOI] [PubMed] [Google Scholar]
  • 14.Yunus M.B., Masi A.T., Aldag J.C. Short term effects of ibuprofen in primary fibromyalgia syndrome: a double-blind, placebo controlled trial. J Rheumatol. 1989;16:527–532. [PubMed] [Google Scholar]
  • 15.Clark S., Tindall E., Bennett R.M. A double-blind cross-over trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol. 1985;12:980–983. [PubMed] [Google Scholar]
  • 16.Scudds R.A., McCain G.A., Rollman Gb y Harth M. Improvement in pain responsiveness in patients with fibrositis after succesfull treatmente with amitriptyline. J Rheumatol. 1989;16(Supl):98–103. [PubMed] [Google Scholar]
  • 17.Moldofsky H. Sllep and fibrositis syndrome. Rheum Dis Clin NA. 1989;15:90–103. [PubMed] [Google Scholar]
  • 18.Carette S., Bell M.J., Reynolds W.J., Haraoui B., McCain G.A., Bykerk V.P. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, doebleblind clinical trial. Arthritis Rheum. 1994;37:32–40. doi: 10.1002/art.1780370106. [DOI] [PubMed] [Google Scholar]
  • 19.Wolfe F., Anderson J., Harkness D., Bennett R.M., Caro X.J., Goldenberg D.L. A prospective, longitudional, multicenter study of service utilization and costs in fibromyalgia (see comments) Arthritis Rheum. 1997;40:1560–1570. doi: 10.1002/art.1780400904. [DOI] [PubMed] [Google Scholar]
  • 20.Fossaluza V., De Vita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharmacol Res. 1992;12:99–102. [PubMed] [Google Scholar]
  • 21.Bennett R.M., Gatter R.A., Campbell S.M., Andrews R.P., Clark S.R., Scarola J.A. A comparison of cyclobenzaprine and placebo in the manegement of fibrositis. A double-blind controlled study. Arthritis Rheum. 1988;31:1535–1542. doi: 10.1002/art.1780311210. [DOI] [PubMed] [Google Scholar]
  • 22.Wolfe F., Cathey M.A., Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255–259. doi: 10.3109/03009749409103725. [DOI] [PubMed] [Google Scholar]
  • 23.Cantini F., BelllandiF, Niccoli L., Di Munno O. Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia (in Italian) Minerva Medica. 1994;85:97–100. [PubMed] [Google Scholar]
  • 24.Goldenberg D.L., Mavssky M., Mossey C. The independent and combined efficacy of fluoxetine and amitrityline in the treatment of fibromyalgia. Arthritis Rheum. 1995;38(Supl):229. [Google Scholar]
  • 25.Wysenbeek A.J., Mor F., Lurie Y., Weinberger A. A imipramine for the treatment of fibrositis. A therapeutic trial. Am Rheum Dis. 1985;44:752–753. doi: 10.1136/ard.44.11.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Carrera J.Q., Castano A.V., Gómez J.P., Rodríguez A.F., Medano W.H., Rubeio A.G. Comparison of tenoxican and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo controlled trial. Pain. 1996;65:221–225. doi: 10.1016/0304-3959(95)00199-9. [DOI] [PubMed] [Google Scholar]
  • 27.Felson D.T., Goldenberg D.L. The natural history of fibromyalgia. Arthritis Rheum. 1986;29:1522–1526. doi: 10.1002/art.1780291216. [DOI] [PubMed] [Google Scholar]
  • 28.Wolfe F., Hawley D.J., Cathey M.A., Caro X., Russell I.J. Fibrositis: symptom frecuency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. J Rheumatol. 1985;12:1159–1163. [PubMed] [Google Scholar]
  • 29.Andreu Sánchez J.L., Barceló García P., Figueras Pedrosa M. Doyma; Barcelona: 1996. Fibromialgia. Otros reumatismos asociados a trastornos psicógenos. Manual de enfermedades reumáticas de la Sociedad Española de Reumatología; pp. 757–764. [Google Scholar]
  • 30.Graciela S., Braley L.A. Advances in the treatment of fibromyalgia: current status and future directions. Am J Med Scien. 1998;315(6):397–404. doi: 10.1097/00000441-199806000-00008. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES